“The global oligonucleotide synthesis market projected to grow at a CAGR of 10.9%.”
The global oligonucleotide synthesis market is expected to reach USD 2.46 billion by 2022 from USD 1.47 billion in 2017 at a CAGR of 10.9%. This market is experiencing significant growth due to the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques.
Growth in this market is mainly driven the increasing R&D expenditure by pharmaceutical and biotechnology companies, rising demand for synthesized oligonucleotides from the growing field of molecular diagnostics, rising venture capital investments, and increasing demand for synthetic genes. However, the price erosion of synthesized oligos and lack of regulations for therapeutic oligos are some factors that may hinder the growth of this market.

“Synthesized oligonucleotides are expected to grow at the highest CAGR during the forecast period.”
Based on product, the market is segmented into synthesized oligonucleotides, reagents, and equipment. The synthesized oligonucleotides segment is expected to grow at the highest CAGR during the forecast period The increasing number of applications of synthesized oligonucleotides in research, diagnostics, and therapeutics is a key market driver in this segment. The rising availability and demand for custom oligos also contribute to the growth of the synthesized oligonucleotides market.

“The research segment is expected to hold the largest share of the market in 2017.”
Based on application, the market is segmented into research, diagnostics, and therapeutics. The research segment is estimated to hold the largest share of the oligonucleotide synthesis market in 2017. The market growth for research applications is mainly driven by the developments in the fields of gene synthesis and NGS. Oligos are widely used in technologies such as PCR, qPCR, gene synthesis, isothermal nucleic acid amplification technology (INAAT), microarray, hybridization, DNA sequencing, and next-generation sequencing (NGS).

“Academic research institutes are expected to dominate the market during the forecast period.”
Based on end user, the market is segmented into academic research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and other end users. The academic research institutes segment is expected to dominate the market during the forecast period. With the increasing funding pouring into institutes to conduct research, the demand for oligonucleotides is bound to increase. To meet this need, companies are launching products and entering into agreements with different research institutes to supply oligonucleotides for research purposes. For instance, in August 2015, Eurofins Genomics launched NGS tests for the identification of non-targeted microorganisms, including 16S Microbiome Profiling for academia and research.

“APAC to witness the highest growth during the forecast period.”

In 2017, North America is expected to account for the largest share of the market followed by Europe. However, Asia Pacific is expected to register the highest CAGR during the forecast period. This can be attributed to factors such as the growing availability of synthesized oligos, along with an increase in R&D funding and activities in the APAC region. The increasing focus of prominent players on APAC is also supporting market growth in the region.
The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 36%; Tier 2 – 46%; Tier 3 – 18%.
• By Designation: C-level- 26%; D-level- 45%; Others- 29%.
• By Region: North America-41%; Europe-31%; Asia Pacific-20%; Latin America- 5%, Middle East and Africa-3%

Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market by providing them with the closest approximations of revenues for the overall oligonucleotide synthesis market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies make suitable go-to-market strategies. The report also will also help stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.

オリゴヌクレオチド合成の世界市場予測2021：プライマー、プローブ、カスタム、デザイン済み、試薬、装置The oligonucleotide synthesis market is expected to reach USD 2.20 Billion by 2021 from USD 1.33 Billion in 2016, at a CAGR of 10.6% from 2016 to 2021. The market is mainly driven by factors such as rising demand for synthesized oligonucleotides due to the growing field of molecular diagnostics, increasing government investments to develop genomic technologies, rising venture capital investments, increasing demand for synthetic genes, and increasing R&D expenditure in pharmaceutical and biotechnological companies. The market in this report is segmented on the basis of products and services, applications, end users, and regions. Based on product and services, the...

オリゴヌクレオチド合成の世界市場Oligonucleotides are single-stranded and short RNA or DNA molecules with applications in research, forensics, and genetic testing. Oligonucleotides are made by chemical synthesis in the laboratory, and are used in therapeutics, cell cultures, library preparations, human identity testing, nucleic acid array-based technology, diagnostics, genetic engineering, next-generation sequencing, synthetic biology, genomics, cloning, and nucleic acid-based detection. Growth in the market is driven by rising demand for synthesized oligonucleotides due to the growing field of molecular diagnostics, increasing government investments to develop genomic technologies, rising venture capital investments, and increasing demand for synthetic genes. The increasing applications of oligonucleotides in nucleic acid...

分子細胞遺伝学の世界市場予測（～2021）：製品別（キット、試薬、プローブ、消耗品、ソフトウェア、サービス）、技術別（ハイブリダイゼーション法(In-Situ)、蛍光染色体ハイブリッド形成(FISH)、比較ゲノムハイブリダイゼーション）、用途別（がん、遺伝）、エンドユーザー別（研究室、研究機関）The molecular cytogenetics market is projected to reach USD 2.52 billion by 2021 from USD 1.55 billion in 2016, at a CAGR of 10.1% from 2016 to 2021. The global molecular cytogenetics market is segmented based on product, technique, application, end user, and region. The kits and reagents segment is expected to register the highest growth rate in the molecular cytogenetics market, by product, during the forecast period. The high growth in this segment is attributed to the increasing number of rental agreements and increasing incidence of genetic disorders and cancer worldwide. However, the high cost of advanced instruments in...

神経モニタリング装置の世界市場予測（～2022年）：神経モニタ、電極、プローブ、付属品The global nerve monitoring system market is projected to reach USD 1.45 Billion by 2022 from USD 1.14 Billion in 2017, at a CAGR of 4.9% during the forecast period. Increased target patient population, clinical benefits associated with nerve monitoring procedures, and the rising use of nerve monitoring in trauma cases are factors expected to drive the demand for nerve monitoring products during the study period. This report broadly segments the nerve monitoring system market into product, technology, application, and end user. On the basis of product, the market is categorized into nerve stimulation electrodes and probes, nerve monitors, and...

血漿分画製剤の世界市場予測（～2023年）：商品別（IVIG(静注免疫グロブリン)、アルブミン、第VIII因子、フォンヴィレブラント因子、PCC (プロトロンビン複合体製剤)、プロテアーゼ阻害剤）、用途別（免疫療法、血液疾患、救命治療、リウマチ）、エンドユーザー別（病院、クリニック、学術研究機関）The plasma fractionation market is projected to reach to USD 29.50 billion by 2023 from an estimated USD 21.23 billion in 2018. The growing geriatric population across the globe, increasing use of immunoglobulins in various therapeutic areas, growing prevalence of respiratory diseases and uptake of alpha-1-antitrypsin, and increase in plasma collection are the factors driving this market. However, the emergence of recombinant alternatives, high cost of plasma products, and limited reimbursement may hinder the growth of this market. The protease inhibitors segment is expected to grow at the highest CAGR during the forecast period On the basis of product, the...

細胞増殖キットの世界市場2018-2022：医薬品・バイオテクノロジー、学術研究機関、その他About Cell Proliferation Kits Cell proliferation kits are assays that deliver the quick and deep quantification of cell proliferation and viability. They are used to analyze pharmaceutical compounds and toxic agents and quantify cell proliferation in the context of growth factors, nutrients, and mitogens. Technavio’s analysts forecast the global cell proliferation kits market to grow at a CAGR of 7.75% during the period 2018-2022. [Covered in this report] The report covers the present scenario and the growth prospects of the global cell proliferation kits market for 2018-2022. To calculate the market size, the report presents a detailed picture of the...

マイクロプレートシステムの世界市場予測（～2022年）：商品別（リーダー (マルチモード (ハイブリッド)・シングルモード)・ディスペンサー・ソフトウェア）、用途別（研究、臨床診断）、エンドユーズ別（バイオテクノロジー、医薬品、病院、診断ラボ）“The global microplate systems market projected to grow at a CAGR of 4.0%.” The global microplate systems market is expected to reach USD 996.9 million by 2022 from USD 820.3 million in 2017 at a CAGR of 4.0%. This market is experiencing significant growth due to increasing R&D expenditure in the pharmaceutical industry, increasing focus on miniaturization, technological advancements, and growing prevalence of diseases. “Microplate Readers are expected to grow at the highest CAGR during the forecast period.” Based on product and service, the market is segmented into microplate readers, microplate pipetting systems and dispensers, microplate washers, and other products....

世界及び中国のオリゴヌクレオチド合成市場2018The 'Global and Chinese Oligonucleotide Synthesis Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Oligonucleotide Synthesis industry with a focus on the Chinese market. The report provides key statistics on the market status of the Oligonucleotide Synthesis manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major industry players in detail. In this part, the report presents...

ヘルスケアサプライチェーン管理の世界市場予測（～2022年）：構成要素別（ソフトウェア（在庫（注文と倉庫管理）、購買（供給元、戦略的ソーシング））ハードウェア（バーコード、RFID））、デリバリーモード（オンプレミス、クラウド）、エンドユーザー別“Healthcare supply chain management market is projected to grow at a CAGR of 8.4%.” The global healthcare supply chain management market is projected to reach USD 2.31 billion by 2022 from an estimated USD 1.55 billion in 2017, growing at a CAGR of 8.4% during the forecast period. Growth in the market can primarily be attributed to factors such as increasing pressure on healthcare providers to improve operational efficiency & profitability, implementation of unique device identification (UDI) by the US FDA, and the emergence of cloud-based solutions. However, the high implementation cost of supply chain management solutions is expected to...

オリゴヌクレオチド・プールの世界市場予測Introduction The Global Oligonucleotide pool market was valued at $ 1,292.8 million in 2016 and expected to reach at $2,324 million by 2022 at a CAGR of 8.5% during the forecast period. The major factors responsible for the growth of global Oligonucleotide pool market are big pharmaceutical companies investing in oligonucleotide therapeutics for drug development, increased involvement of CMOs in manufacturing therapeutic oligonucleotides and wide application areas offered by the oligonucleotides, among others. The growth barriers are complexity in the technology of manufacturing oligonucleotides and inaccuracy issues for the specific oligonucleotides among others. The market is majorly categorized on the...

ヘルスケア不正利用検知の世界市場予測（～2022年）：種類別（記述的、規定的）、用途別（保険給付、前払い、後払い）、構成要素別（サービス、ソフトウェア）、デリバリー別（オンプレミス、クラウド）、エンドユーザー別（保険支払人、私的、公的）“Global healthcare fraud detection market projected to grow at a CAGR of 28.9%” The healthcare fraud detection market is expected to reach USD 2,242.7 million by 2022 from USD 631.0 million in 2017, at a CAGR of 28.9%. Factors such as the large number of fraudulent activities in healthcare; increasing number of patients seeking health insurance; the prepayment review model; growing pressure of fraud, waste, and abuse on healthcare spending; and high returns on investments are driving the growth of the healthcare fraud detection market. On the other hand, market growth is likely to be negatively affected by the dearth...

ガイドワイヤーの世界市場予測（～2022年）：材料別（ニチノール、ステンレス鋼、ハイブリッド）、商品別（外科、診断（親水性、疎水性））、用途別（循環器、血管、神経、GIT、ENT、泌尿器、腫瘍）、エンドユーザー別（病院、ASC）The guidewires market projected to grow at a CAGR of 4.8% The global guidewires market is projected to reach USD 764.0 million by 2022 from USD 605.2 million in 2017, at a CAGR of 4.8%. The growth witnessed by guidewires is mainly driven by growing target disease incidence, continuous product commercialization by major manufacturers and favorable medical reimbursements for guidewires in developed countries. The government initiatives to control the burden of healthcare-associated infections (HAIs) in developed countries and the increasing healthcare expenditure across emerging markets are also driving the growth of the market. However, high cost of surgical guidewires, spending...

生体機能チップの世界市場予測（～2022年）：種類別（肝臓、腎臓、肺、心臓、腸、消化管）、提供物別（製品、サービス）、用途別（毒性試験、生理学的モデル）、エンドユーザー別（学術、研究機関、製薬会社）The organs-on-chips market is expected to reach USD 45.6 Million by 2022 from USD 9.6 Million in 2017, at a CAGR of 36.6%. The growth of this market is mainly driven by the growing focus on developing alternatives for animal testing models, significant increase in research funding and venture capital investments for the development of organs-on-chips, technological advancements and new products launches, growing number of partnerships and collaborations between pharmaceutical companies and organs-on-chips manufacturers, and growing need for early detection of drug toxicity to minimize financial losses due to late stage drug failure. This report segments the organs-on-chips market into...

天井用タイルの世界市場予測（～2022年）：材料タイプ別（鉱物繊維、金属、石膏）、特性タイプ別（吸音、非吸音）、エンドユーザー別（住宅、非住宅）、地域別（北米、欧州、アジア太平洋地域 、中東・アフリカ、南米）“The ceiling tiles market is projected to grow at a CAGR of 6.2% from 2017 to 2022, in terms of value.” The ceiling tiles market is estimated to be USD 7.31 billion in 2017 and is projected to reach USD 9.88 billion by 2022, at a CAGR of 6.2% between 2017 and 2022. The increasing demand for ceiling tiles in building & construction projects is one of the most significant factors projected to drive the growth of the ceiling tiles market. Superior properties of ceiling tiles such as improved sound absorption capability and easy installation and recyclability are also contributing...